Related Experiment Video

Updated: May 11, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Thymoquinone induces apoptosis in oral cancer cells through p38β inhibition

Ehab Abdelfadil1, Ya-Hsin Cheng, Da-Tian Bau

  • 1Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan.

The American Journal of Chinese Medicine
|May 29, 2013
PubMed

Insights

This study investigated p38 mitogen-activated protein kinase (MAPK) in oral cancer, finding p38β is linked to its development. The anti-cancer compound thymoquinone (TQ) shows promise by downregulating p38β.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Oral cancer presents significant morbidity and mortality.
  • The specific roles of p38 MAPK family members in oral cancer remain largely undefined.
  • p38 MAPK signaling pathways regulate crucial cellular processes like proliferation and differentiation.

Purpose of the Study:

  • To investigate the involvement of p38 MAPK family members in oral cancer development.
  • To explore the anti-cancer potential of thymoquinone (TQ) in oral cancer.
  • To elucidate the molecular mechanisms underlying TQ's anti-tumor effects.

Main Methods:

  • Utilized two unique cell lines: chemically induced oral cancer cells (T28) and adjacent non-tumor cells (N28).
  • Screened for the involvement of p38 MAPK in malignant transformation processes.
  • Assessed the anti-cancer activity of thymoquinone (TQ) and its effect on p38 MAPK signaling.

Main Results:

  • Results indicate a significant association between p38β, but not p38α, and oral cancer development.
  • Thymoquinone (TQ) demonstrated anti-cancer activity in the studied oral cancer model.
  • Evidence suggests TQ's anti-tumor effects are mediated through the downregulation of p38β MAPK.

Conclusions:

  • p38β MAPK is implicated in the development of oral cancer.
  • Thymoquinone (TQ) exhibits therapeutic potential against oral cancer.
  • Targeting p38β MAPK with agents like TQ may represent a viable strategy for oral cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...